GlassScriptPhysician profile
Berjesh Sharda
NPI 1962002576
$6,080.44
in general payments reported to CMS, 2019-2025
20 companies · $383 in 2025
The $383 reported for 2025 was less than what a typical Transplant Surgery provider received nationally (typical 2025 total: $423).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $94.43 · 2022: $2,261 · 2023: $3,029 · 2024: $313 · 2025: $383.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,500 · Travel and Lodging: $1,132 · Food and Beverage: $1,093.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,500.00 |
| Travel and Lodging | $1,131.82 |
| Food and Beverage | $1,092.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,064.04 | 2022-2023 | Davinci Xi, Da Vinci Surgical System |
| Janssen Biotech, INC. | $138.66 | 2024-2025 | Erleada, Akeega, Balversa |
| Medtronic, INC. | $123.79 | 2023-2025 | Endurant Iis, Interstim |
| Sumitomo Pharma America, INC. | $111.32 | 2023-2025 | Gemtesa, Orgovyx |
| Axonics, INC. | $108.20 | 2023-2024 | Axonics |
| Avanos Medical | $94.43 | 2021 | |
| Ethicon US, LLC | $66.04 | 2025 | Vistaseal, Surgiflo Hemostatic Matrix |
| Calyxo, INC. | $57.49 | 2025 | Cvac Aspiration System |
| Procept Biorobotics Corporation | $55.29 | 2025 | |
| Cumberland Pharmaceuticals, INC. | $36.48 | 2024 | Caldolor |
| Abbvie INC. | $33.92 | 2024 | |
| Ferring Pharmaceuticals INC. | $33.91 | 2024-2025 | Adstiladrin |
| Laborie Medical Technologies Corp. | $30.64 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Boston Scientific Corporation | $28.31 | 2024-2025 | Ams 700 |
| Coloplast Corp | $18.82 | 2023 | Porges Coloplast |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $18.14 | 2023 | Urolift |
| Smith+Nephew, INC. | $17.33 | 2023 | Grafix Pl |
| Urogen Pharma, INC. | $15.17 | 2025 | |
| Pfizer INC. | $14.69 | 2025 | |
| Endo Pharmaceuticals INC. | $13.77 | 2023 | Xiaflex, Aveed |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Berjesh Sharda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.